The measurement of company-led education is evolving beyond simply reach and participation.
Drawing on research into lung cancer care, this white paper from Medscape Medical Affairs examines what happens when it is evaluated against real-world treatment activity — and asks whether program-level engagement provides a more complete picture.
31%
higher rate of evidence-based targeted therapy use than matched non-learners, in the six months after engagement
+2.6
patients per 100 clinicians receiving evidence-based therapy with each additional activity
+11.2
additional patients with evidence-based treatment for every 100 clinicians educated
Download White Paper
"*" indicates required fields
